2006-2010 Bachelor's Degree: Beijing Normal University
2010-2015 Doctoral Degree: Fudan University
Clarivate Highly Cited Researcher 2023
World's Top 2% Scientists 2023 (Elsevier/Stanford)
2015-2019 - Rockefeller University - Postdoctoral Researcher
2020-2021 - Columbia University - Associate Researcher Scientist
2021-Present - Fudan University - Junior Professor
Clarivate Highly Cited Researcher 2023
World's Top 2% Scientists 2023 (Elsevier/Stanford)
Research
Antiviral therapeutics and vaccines
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster., Wang X, Jiang S, Ma W, Li X, Wei K, Xie F, Zhao C, Zhao X, Wang S, Li C, Qiao R, Cui Y, Chen Y, Li J, Cai G, Liu C, Yu J, Li J, Hu Z, Zhang W, Jiang S, Li M, Zhang Y, Wang P, 2023
Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by Breakthrough Infection Sera from Previous and Recent Waves in China., Wang X, Jiang S, Jiang S, Li X, Ai J, Lin K, Lv S, Zhang S, Li M, Li J, Dai L, Hu Z, Zhang W, Zhang Y, Wang P, 2023
Limited enhancement of antibody and B-cell responses to prototype booster vaccination following SARS-CoV-2 Delta breakthrough infection., Wang X, He X, Jiang S, Fu Z, Jiang S, Zhao X, Zhao C, Li Y, Li D, Zhang W, Ai J, Zhang Y, Xu C, Wang P, 2023
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses., Chen Y, Zhao X, Zhou H, Zhu H, Jiang S, Wang P, 2023
Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination., Wang H, Xue Q, Zhang H, Yuan G, Wang X, Sheng K, Li C, Cai J, Sun Y, Zhao J, Lu J, Fang S, Yang Y, Zhang Y, Huang Y, Wang J, Xu JH, Jiang MX, Wang X, Shen L, Liu Y, Liu Q, Zhang Q, Wang S, Wang P, Qiu C, Ai J, Zhang W, 2023
Structure-based virtual screening of ROCK1 inhibitors for the discovery of Enterovirus-A71 antivirals., Qiao R, Tang W, Li J, Li C, Zhao C, Wang X, Li M, Cui Y, Chen Y, Cai G, Wu Q, Zhao X, Wang P, 2023
In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG., Wang X, Li M, Lu P, Li C, Zhao C, Zhao X, Qiao R, Cui Y, Chen Y, Li J, Cai G, Wang P, 2023
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2 and BA.3 sub-lineages., Ai J, Wang X, He X, Zhao X, Zhang Y, Jiang Y, Li M, Cui Y, Chen Y, Qiao R, Li L, Yang L, Li Y, Hu Z, Zhang W, Wang P, 2022
Neutralization of Omicron BA.4/BA.5 and BA.2.75 by Booster Vaccination or BA.2 Breakthrough Infection Sera., Wang X, Ai J, Li X, Zhao X, Wu J, Zhang H, He X, Zhao C, Qiao R, Li M, Cui Y, Hu Z, Xu C, Zhang W, Wang P, 2022
Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies., Wang X, Zhao X, Song J, Wu J, Zhu Y, Li M, Cui Y, Chen Y, Yang L, Liu J, Zhu H, Jiang S, Wang P, 2022
Rock1 is a novel host dependency factor of human enterovirus A71: implication as a drug target., Zhao X, Li C, Chiu MC, Qiao R, Jiang S, Wang P, Zhou J, 2022
Neutralization of distinct Omicron sublineages by longitudinal vaccination sera., Wang X, Zhao X, Cui Y, Qiao R, Li M, Chen Y, Yang L, Jiang S, Wang P, 2022
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7., Wang P, Nair MS, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS, Mascola JR, Chang JY, Yin MT, Sobieszczyk M, Kyratsous CA, Shapiro L, Sheng Z, Huang Y, Ho DD, 2021
Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization., Wang P, Casner RG, Nair MS, Wang M, Yu J, Cerutti G, Liu L, Kwong PD, Huang Y, Shapiro L, Ho DD, 2021
Potent Neutralizing Monoclonal Antibodies Directed to Multiple Epitopes on the SARS-CoV-2 Spike., Liu L, Wang P, Nair MS, Yu J, Rapp MA, Wang Q, Luo Y, Sahi V, Figueroa A, Guo XV, Cerutti G, Bimela J, Gorman J, Zhou T, Kwong PD, Sodroski JG, Yin MT, Sheng Z, Huang Y, Shapiro L, Ho DD, 2020
Identification of SARS-CoV-2 Inhibitors using Lung and Colonic Organoids., Han Y, Duan X, Yang L, Nilsson-Payant BE, Wang P, Duan F, Tang X, Yaron TM, Zhang T, Uhl S, Bram Y, Richardson C, Zhu J, Zhao Z, Redmond D, Houghton S, Nguyen D, Xu D, Wang X, Jessurun J, Borczuk A, Huang Y, Johnson JL, Liu Y, Xiang J, Wang H, Cantley LC, tenOever BR, Ho DD, Pan FC, Evans T, Chen HJ, Schwartz RE, Chen S, 2021
Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo., Wang P, Gajjar MR, Yu J, Padte NN, Gettie A, Blanchard JL, Russell-Lodrigue K, Liao LE, Perelson AS, Huang Y, Ho DD, 2020
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses., Wang P, Casner RG, Nair MS, Yu J, Guo Y, Wang M, Chan JF, Cerutti G, Iketani S, Liu L, Sheng Z, Chen Z, Yuen KY, Kwong PD, Huang Y, Shapiro L, Ho DD, 2022
SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease., Wang P, Liu L, Nair MS, Yin MT, Luo Y, Wang Q, Yuan T, Mori K, Solis AG, Yamashita M, Lawrence J, Purpura LJ, Laracy JC, Yu J, Sodroski JG, Huang Y, Ho DD, 2020
Anti-HIV Passive Immunization in Animal Models., Wang P, 2018
Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui., Wang P, Lu P, Qu X, Shen Y, Zeng H, Zhu X, Zhu Y, Li X, Wu H, Xu J, Lu H, Ma Z, Zhu H, 2017
Two cellular microRNAs, miR-196b and miR-1290, contribute to HIV-1 latency., Wang P, Qu X, Zhou X, Shen Y, Ji H, Fu Z, Deng J, Lu P, Yu W, Lu H, Zhu H, 2015
Specific reactivation of latent HIV-1 with designer zinc-finger transcription factors targeting the HIV-1 5′-LTR promoter., Wang P, Qu X, Wang X, Zhu X, Zeng H, Chen H, Zhu H, 2014
As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB., Wang P, Qu X, Wang X, Liu L, Zhu X, Zeng H, Zhu H, 2013
Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells., Qu X, Wang P, Ding D, Li L, Wang H, Ma L, Zhou X, Liu S, Lin S, Wang X, Zhang G, Liu S, Liu L, Wang J, Zhang F, Lu D, Zhu H, 2013
HIV-1 Co-Receptor Usage Based on V3 Loop Sequence Analysis: Preferential Suppression of CXCR4 Virus Post HAART?, Jiao Y, Wang P, Zhang H, Zhang T, Zhang Y, Zhu H, Wu H, 2011
Area of Focus
Immunology | B-Cells | Antibodies | Somatic Hypermutation | Pathogens | Autoimmunity | Gut Microbiome | Host Interactions | Vaccines | Traditional Chinese Medicine
